BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2020
View Archived Issues
BCHT's live attenuated influenza virus vaccine receives approval in China
Read More
Finding the silent majority
Read More
First-in-human data for EHP-101
Read More
New phase III trials evaluate switch to doravirine/islatravir in HIV patients on other regimens
Read More
Increasing immune activity improves autoimmunity
Read More
IPA enters AI collaboration to develop therapeutics and vaccines against SARS-CoV-2 coronavirus
Read More
Nitto Denko initiates phase II study in Japan with ND-L02-s0201 for IPF
Read More
Dynavax, University of Queensland and CEPI collaborate to develop COVID-19 vaccine
Read More
Phase I results presented for rongliflozin
Read More
Tissue kallikrein as a new serum biomarker to predict DCI following aSAH
Read More
Kikkoman, Chiba University patent high-affinity IgE receptor suppressors
Read More
Leo Pharma synthesizes new RORgammaT ligands
Read More
New IRAK-4 inhibitors identified at Gilead
Read More
New antibacterials discovered at Recreo Pharmaceuticals
Read More
Merck & Co. discloses new IDO-1 inhibitors
Read More
Tau protein plays role in autism spectrum disorder
Read More
XIST is a novel therapeutic target for treating laryngeal squamous cell carcinoma
Read More
SIGA agrees to provide Tpoxx in support of Turnstone's SKV vaccinia oncolytic immunotherapy program
Read More
Cytoo and Asklepios collaborate to select gene therapy candidate for rare muscle disorder
Read More
Mutated TTC12 causes primary ciliary dyskinesia, revealing diverse dynein assembly in cilia/flagella
Read More
Phase III BOSTON study of Xpovio in multiple myeloma meets primary endpoint
Read More
Sarclisa receives FDA approval for relapsed refractory multiple myeloma
Read More
Unum prioritizes resources on advancement of BOXR-1030
Read More
Tilt opens first-in-human study of oncolytic adenovirus TILT-123 for metastatic melanoma
Read More
Omeros reports new data from pivotal trial of narsoplimab for HSCT-TMA
Read More